Simon Roofing gets BBB accreditation

Simon Roofing gets BBB accreditation

BOARDMAN

Simon Roofing, a national commercial roofing company with its corporate offices on Karago Avenue, earned accreditation and an A+ rating from the Better Business Bureau for its locations in Ohio, North Carolina, Tennessee, Florida, Louisiana and California.

Simon Roofing maintains 64 service centers around the country, employing more than 400 people. In addition to roofing, the company’s Simon Surfaces division offers commercial concrete repair and resurfacing solutions.

Farmers unveils new services

CANFIELD

Farmers National Bank unveiled updated online and mobile banking services Monday.

These services include: Popmoney, a service in which customers can either send or request money to or from another person via text or email; live chat (coming soon), a feature that will allow customers to communicate with a Farmers representative through online chat in real time; and finance manager, a budgeting tool that categorizes expenses, sets savings goals and aggregates customers’ accounts from any financial institution.

The services also offer remote deposit capture, picture pay and PIN login.

US indexes slide

new york

The stock market slumped Monday, unable to shake off worries of a global economic slowdown and plunging oil prices.

Airlines, energy and materials stocks were among the biggest decliners. Stocks are coming off their worst week in more than two years.

The downturn leaves the Standard & Poor’s index 500 down 6.8 percent from its recent peak last month and up just 1.4 percent for the year.

Many investors remain concerned that growth in Europe and Asia could be slowing. A meeting of eurozone finance ministers in Luxembourg didn’t appear to allay those fears.

Canadian Ebola vaccine begins tests

TORONTO

Human testing of an experimental Canadian-made Ebola vaccine began Monday, with federal officials saying the drug could be shipped to West Africa within months if it proves successful.

Health Minister Rona Ambrose said the launch of the vaccine’s first clinical trial marks a promising step in the global campaign to contain the virus, which the World Health Organization says has killed more than 4,000 people, mostly in the West African countries of Liberia, Sierra Leone and Guinea.

Twenty vials of the vaccine have been sent to the Walter Reed Army Institute of Research in Maryland for testing on about 40 healthy volunteers, she said.

The Phase 1 trial will determine if the vaccine created by Public Health Agency of Canada and known as VSV-EBOV is safe for human use. It also will determine the proper dosage level and test for possible side effects, Ambrose said.

Vindicator staff/wire reports